-308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter

Journal of Inflammation

Volumn 46, Issue 1, 1996, Pages 42-50

  Stuber, Frank ^a,c   Udalova, Irina A ^a   Book, Malte ^b   Drutskaya, Ludmila N ^c   Kuprash, Dmitry V ^d   Turetskaya, Regina L ^e   Ulrich Schade, F ^a   Nedospasov, Sergei A ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^d MOSCOW STATE UNIVERSITY   (Russian Federation)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

gene; LPS; macrophage; polymorphism; sepsis; TNF; transcription

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROMOTER REGION; SEPSIS; SEPTIC SHOCK;

EID: 0029880580     PISSN: 10787852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664, 1987.
2. Waage A, Halstensen A, Espevik T: Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355-357, 1987.
3. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, Lambert PH: Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 319:397-400, 1988.
4. Debets JM, Kampmeijer R, van der Linden MP, Buurman WA, van der Linden CJ: Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 17:489-494, 1989.
5. Jongeneel CV: Regulation of the TNF alpha gene. Prog Clin Biol Res 388:367-381, 1994.
6. Shakhov AN, Collait MA, Vassalli P, Nedospasov SA, Jongeneel CV: Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 171:35-47, 1990.
7. Collait MA, Baeuerle P, Vassalli P: Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 10:1498-1506, 1990.
8. Wilson AG, di Giovine FS, Blakemore AI, Duff GW: Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1:353, 1992.
9. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D: Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371:508-510, 1994.
10. Wilson AG, Gordon C, di Giovine FS, de Vries N, van de Putte LB, Emery P, Duff GW: A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 24:191-195, 1994.
11. Pociot F, Wilson AG, Nerup J, Duff GW: No independent association between a tumor necrosis factoralpha promotor region polymorphism and insulin-de-pendent diabetes mellitus. Eur J Immunol 23:30503053, 1993.
12. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P: Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237:1210-1212, 1987.
13. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH: Tumor necrosis factor and disease seventy in children with falciparum malaria. N Engl J Med 320:1586-1591, 1989.
14. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A: Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23:224-231, 1993.
15. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, Riethmuller G, Weiss EH: Polymorphic structure of the tumor necrosis factor (TNF) locus: An Ncol polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 173:209-219, 1991.
16. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992.
17. Goris RJ, te Boekhorst TP, Nuytinck JK, Gimbrere JS: Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg 120:1109-1115, 1985.
18. Redl H, Schlag G, Bahrami S, Schade U, Ceska M, Stutz P: Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model. J Infect Dis 164:383-388, 1991.
19. Webb GC, Chaplin DD: Genetic variability at the human tumor necrosis factor loci. J Immunol 145:1278-1285, 1990.
20. Stuber F, Petersen M, Bokelmann F, Schade FU: A genomic polymorphism within TNF locus influences TNF-alpha plasma levels and outcome in patients with severe sepsis. Crit Care Med (in press).
21. Nedospasov SA, Shakhov AN, Turetskaya RL, Me VA, Azizov MM, Georgiev GP, Korobko VG, Dobrynin VN, Filippov SA, Bystrov NS, Boldyreva EF, Chuvpilo SA, Chumakov AM, Shingarova LN, Ovchinnikov YA: Tandem arrangement of genes coding for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) in the human genome. Cold Spring Harbor Symp Quant Biol 51:611-624, 1986.
22. Udalova IA: Transcriptional regulation of the human TNF gene in monocytes and macrophages. Ph.D. thesis, Institute of Bioorganic Chemistry, Moscow, 1995.
23. McPherson MJ, Taylor G, Quirke P: "PCR: A Practical Approach." New York: Oxford University Press, 1991.
24. Cox GW, Mathieson BJ, Gandino L, Blasi E, Radzioch D, Varesio L: Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl Cancer Inst 81:1492-1496, 1989.
25. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW: An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with H LA AI, B8, and DR3 alleles. J Exp Med 177:557-560, 1993.
26. Brinkman BM, Giphart MJ, Verhoef A, Kaijzel EL, Naipal AM, Daha MR, Breedveld FC, Verweij CL: Tumor necrosis factor alpha-308 gene variants in relation to major histocompatibility complex alleles and Felly's syndrome. Hum Immunol 41:259-266, 1994.
27. Verjans GM, Brinkman BM, Van Doornik CE, Kijlstra A, Verweij CL: Polymorphism of tumour necrosis factoralpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 97:45-47, 1994.
28. Biragyn A, Nedospasov SA: Lipopolysaccharide-induced expression of TNF-alpha gene in the macrophage cell line ANA-1 is regulated at the level of transcription processivity. J Immunol 155:674-683, 1995.
29. Udalova IA, Turetskaya RL, Kuprash DV, Nedospasov SA: Two-step activation of human TNF gene transcription in macrophages. Role of NF-icB/Rel family members in LPS activation. Proc RUSS Acad Sci (Dokl Akad Nauk) 342:413-417, 1995.
30. Kuprash DV, Turetskaya RL, Boldin MP, Udalova IA, Kistanova EM, Smirnova JB, Nedospasov SA: Structure and regulation of tumor necrosis factor genes at genomic loci. In Fiers W, Buurman WA (eds): "Tumor Necrosis Factor and Related Cytokines: Molecular and Cellular Biology and Clinical Relevance." Basel: S. Karger, 1993.
31. Ziegler-Heitbrock HW, Thiel E, Futterer A, Herzog V, Wirtz A, Riethmuller G: Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 41:456-461, 1988.
32. Messer G, Kick G, Ranki A, Koskimies S, Reunala T, Meurer M: Polymorphism of the tumor necrosis factor genes in patients with dermatitis herpetiformis. Dermatology 189(Suppl 11:135-137, 1994.
33. Browning JL, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow EP, Hession C, O'Brine-Greco B, Foley SF, Ware CF: Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847-856, 1993.
34. McDonnell PC, DiLella AG, Lee JC, Young PR: Localization of the human stress responsive MAP kinase-like CSAIDs binding protein (CSBP) gene to chromosome 6p21.3/21.2. Genomics 29:302-304, 1995.
35. Holzinger l, de Baey A, Messer G, Kick G, Zwierzina H, Weiss EH: Cloning and genomic characterization of LST1 : A new gene in the human TNF region. Immunogenetics 42:315-322, 1995.
36. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL: Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 16:180-186, 1993.
37. Monos DS, Kamoun M, Udalova IA, Csanky E, Cizman B, Turetskaya RL, Smirnova JB, Zharkov VG, Gasser D, Zmijewski CM, Spielman RS, Nedospasov SA: Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus. Linkage disequilibrium of TNFab microsatellite alleles with H LA haplotypes. Hum Immunol 44:70-79, 1995.
38. Brinkmann BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL: Relevance of the TNF-alpha -308 promoter polymorphism in the TNF-alpha gene regulation. Journal of Inflammation 46:32-41, 1996.
39. Albertella MR, Campbell RD: Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins. Hum Mol Genet 3:793-799, 1994.
40. Han J, Lee JD, Bibbs L, Ulevitch RJ: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811, 1994.
41. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739746, 1994.